These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27299424)

  • 1. Remission in Pediatric Inflammatory Bowel Disease Correlates With Prescription Refill Adherence Rates.
    Samson CM; Mager D; Frazee S; Yu F
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):575-579. PubMed ID: 27299424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.
    de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI
    Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease.
    Tae CH; Jung SA; Moon HS; Seo JA; Song HK; Moon CM; Kim SE; Shim KN; Jung HK
    J Clin Gastroenterol; 2016 Feb; 50(2):157-62. PubMed ID: 26501880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
    Lenti MV; Selinger CP
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
    Kluthe C; Tsui J; Spady D; Carroll M; Wine E; Huynh HQ
    Can J Gastroenterol Hepatol; 2018; 2018():4687041. PubMed ID: 29682493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease.
    San EH; Egberts A; van Dijck-van Boetzelaer CWT; West RL; Vasbinder EC
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1089-1096. PubMed ID: 38553558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
    Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
    J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence.
    Trindade AJ; Ehrlich A; Kornbluth A; Ullman TA
    Inflamm Bowel Dis; 2011 Feb; 17(2):599-604. PubMed ID: 20848512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying predictors of low adherence in patients with inflammatory bowel disease.
    Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.
    Kane S; Becker B; Harmsen WS; Kurian A; Morisky DE; Zinsmeister AR
    Am J Gastroenterol; 2012 Feb; 107(2):154-60. PubMed ID: 22306937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Text Messaging Effect on Adherence in Children With Inflammatory Bowel Disease.
    Miloh T; Shub M; Montes R; Ingebo K; Silber G; Pasternak B
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):939-942. PubMed ID: 27602705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.
    Selinger CP; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Smith P; Lal S; Leong RW; McLaughlin J; Robinson A
    Inflamm Bowel Dis; 2013 Sep; 19(10):2199-206. PubMed ID: 23899547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S; Noble A; Deslandres C
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic.
    Bhasin S; Singh H; Targownik LE; Israeli E; Bernstein CN
    Inflamm Bowel Dis; 2016 Apr; 22(4):919-24. PubMed ID: 26933748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory bowel disease].
    Patuto N; Beglinger C
    Praxis (Bern 1994); 2013 Aug; 102(17):1046-52. PubMed ID: 23965717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios.
    Selinger CP; Ochieng AO; George V; Leong RW
    Inflamm Bowel Dis; 2019 Apr; 25(5):919-924. PubMed ID: 30265299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.